Benztropine 2 mg Tablets — Generic For Cogentin — Leading Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Benztropine mesylate tablets are prescription tablets for oral use that come in 0.5 mg, 1 mg, and 2 mg strengths. The label says they are used as an adjunct in the treatment of all forms of parkinsonism.

The tablets are also used to help control extrapyramidal disorders caused by neuroleptic drugs, such as phenothiazines, except for tardive dyskinesia. The label notes that treatment should be individualized and started at low doses, with gradual increases as needed.

Benztropine has anticholinergic effects and can cause side effects such as dry mouth, blurred vision, constipation, urinary retention, confusion, hallucinations, and drowsiness or weakness. The label also warns that it may impair the ability to drive or operate machinery and that heat-related problems can occur, especially with certain other medicines.

Storage Information

Store at 20° to 25° C (68° to 77°F); excursions permitted to 15° to 30° C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in well-closed containers as defined in the USP.

Key Counseling Points

• Take this medicine exactly as prescribed; the label says dosing should be started low and increased gradually.
• It is used for parkinsonism and for some drug-induced movement problems, but not for tardive dyskinesia.
• This medicine may cause dry mouth, blurred vision, constipation, nausea, urinary retention, or weakness.
• It may cause confusion, excitement, hallucinations, or worsening of mental symptoms in some patients.
• Use caution with activities like driving or operating machinery because the drug may impair mental or physical abilities.
• Tell a clinician promptly about fever, heat intolerance, or decreased sweating, especially if taking other anticholinergic or antidopaminergic drugs.
• Heat-related illness, including hyperthermia and heat stroke, has been reported with anticholinergic-type drugs.
• Do not stop other antiparkinsonian medicines abruptly when benztropine is started; the label says changes should be gradual.
• The label says to use caution in patients with glaucoma, prostatic hypertrophy, tachycardia tendency, or urinary retention problems.
• Keep this medicine out of reach of children.

Helpful Patient Education

Benztropine mesylate tablets are prescription oral tablets available in 0.5 mg, 1 mg, and 2 mg strengths. According to the DailyMed label, they are used as an adjunct treatment for parkinsonism and for certain extrapyramidal disorders caused by neuroleptic drugs, except tardive dyskinesia.

Educational product information should also note important labeled precautions, including possible anticholinergic side effects such as dry mouth, blurred vision, constipation, urinary retention, confusion, and heat-related reactions. The label advises gradual dose adjustment and careful observation during treatment.

Medication Summary last generated: 2026-07-10 02:58:24